Common blood pressure drug helps more stroke survivors reach critical health target
AI Image

Common blood pressure drug helps more stroke survivors reach critical health target

Fox News • • health

Key Points:

  • A new study called the REDUCE trial found that adding spironolactone, a low-cost water pill, to post-stroke treatment significantly lowered blood pressure in stroke survivors whose levels remained high despite usual care.
  • After three months, patients taking spironolactone had an average systolic blood pressure nearly eight points lower than those on standard treatment, with 52% reaching the recommended goal of less than 130/80 compared to 30% in the control group.
  • While the medication shows promise in reducing blood pressure, experts caution that the study did not assess whether spironolactone prevents subsequent strokes or heart attacks, and safety concerns like high potassium levels require monitoring.
  • The trial ended early with fewer participants than planned and had some data limitations, indicating that larger, longer studies are necessary to confirm the medication's long-term benefits and safety for stroke survivors.
  • Physicians advise patients with uncontrolled blood pressure after a stroke to discuss the potential use of spironolactone with their healthcare providers, considering individual risks and monitoring needs.

Trending Business

Trending Technology

Trending Health